Pancreatic Cancer Research

ResearcherUniversity of ToyamaNo recent work listed

Koichi Tsuneyama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0670-9868; OpenAlex author ID A5019715351. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

  1. Inhibition of EP2/EP4 prostanoid receptor-mediated signaling suppresses IGF-1-induced proliferation of pancreatic cancer BxPC-3 cells via upregulating γ-glutam… Co-author DOI 10.1016/j.bbrc.2019.06.054↗
  2. Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44. Last author DOI 10.3892/ol.2012.657↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takao Hijikata · 1 shared paper, 2019 · strength 0.12
  2. Tetsuyuki Takahashi · 1 shared paper, 2019 · strength 0.12
  3. S Kitamura · 1 shared paper, 2012 · strength 0.02
  4. Isamu Makino · 1 shared paper, 2012 · strength 0.02
  5. Tetsuo Ohta · 1 shared paper, 2012 · strength 0.02
  6. Itasu Ninomiya · 1 shared paper, 2012 · strength 0.02
  7. Hidehiro Tajima · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.